Michael Hufford
Directeur Général chez LyGenesis, Inc.
Profil
Michael Hufford was the founder of e-Nicotine Technology, Inc. where he held the title of Chief Medical Officer & Director.
He is also the founder of LyGenesis, Inc. Dr. Hufford's current job is as a Director at Morphoceuticals, Inc.
Postes actifs de Michael Hufford
| Sociétés | Poste | Début |
|---|---|---|
LyGenesis, Inc.
 LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Directeur Général | 01/05/2018 |
Morphoceuticals, Inc.
 Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Hufford
| Sociétés | Poste | Fin |
|---|---|---|
e-Nicotine Technology, Inc.
 e-Nicotine Technology, Inc. BiotechnologyHealth Technology e-Nicotine Technology, Inc. develops next generation of state-of-the-art electronic nicotine delivery products. It engages in developing electronic nicotine delivery devices that produce a condensation aerosol of nicotine using its thermal drug delivery technology. The firm’s devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was founded by Jeffrey S. Williams, Michael Hufford and Martin Wensley in 2012 and is headquartered in Draper, UT. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
e-Nicotine Technology, Inc.
e-Nicotine Technology, Inc. BiotechnologyHealth Technology e-Nicotine Technology, Inc. develops next generation of state-of-the-art electronic nicotine delivery products. It engages in developing electronic nicotine delivery devices that produce a condensation aerosol of nicotine using its thermal drug delivery technology. The firm’s devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was founded by Jeffrey S. Williams, Michael Hufford and Martin Wensley in 2012 and is headquartered in Draper, UT. | Health Technology |
LyGenesis, Inc.
LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Health Technology |
Morphoceuticals, Inc.
Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Commercial Services |